Fariz Habib, MD
Neurology · Lansing, KSNPI 1992765317
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by EMD Serono, Inc. at 32.7% of the total. Reporting peaked in 2020 at $651 and has fallen 59.0% since, to $267 in 2025.
Across 195 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$1K
- UCB, Inc.$273
- Biogen$247
- Eisai Inc.$181
- Bristol Myers Squibb$131
- SK Life Science, Inc.$109
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$993%
- Food & beverage$3,57097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,669 in reported general payments places this provider in the 70th percentile of 131 neurology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine ErCarbamazepine | 27 | $6,321 |
| Memantine Hcl | 175 | $4,981 |
| Gabapentin | 224 | $4,774 |
| Divalproex Sodium | 40 | $3,877 |
| Levetiracetam | 90 | $3,715 |
| Carbamazepine | 26 | $1,980 |
| Propranolol Hcl ErPropranolol Hcl | 46 | $1,629 |
| Pregabalin | 30 | $1,389 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 23 | $1,003 |
| Primidone | 67 | $969 |
| Donepezil Hcl | 88 | $819 |
| Ropinirole Hcl | 39 | $709 |
| Phenytoin Sodium Extended | 14 | $498 |
| Tizanidine Hcl | 62 | $494 |
| Cyclobenzaprine Hcl | 27 | $467 |
Paid to pharmacies, not to this prescriber.
Other neurology in Lansing
- Ivan OsorioKansas City$101.7M
- Jeffrey KaplanLenexa$1.9M
- Rajesh PahwaKansas City$889K
- Sheetal MalikTopeka$137K
- Richard DubinskyKansas City$122K
- Barbara Jean OttleyHays$116K
- Jeffrey BurnsKansas City$115K
- Douglas DavisSalina$100K
- Amanda ThuringerKansas City$87K
- Mamatha PasnoorKansas City$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.